Published in J Immunol on March 01, 1998
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A (2000) 5.07
Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med (2000) 3.74
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A (2005) 2.52
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut (2003) 2.37
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun (2002) 1.84
H pylori colocalises with MUC5AC in the human stomach. Gut (2000) 1.78
Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut (2003) 1.77
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect Immun (2004) 1.66
Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep (2009) 1.63
Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect Immun (2002) 1.59
Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. Infect Immun (2001) 1.33
Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun (2001) 1.32
Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun (2007) 1.32
Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect Immun (2002) 1.24
Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect Immun (2000) 1.23
The Chemokine CXCL8 in Carcinogenesis and Drug Response. ISRN Oncol (2013) 1.22
Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect Immun (2003) 1.19
Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect Immun (2000) 1.19
Role of NF-kappaB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS cells. Dig Dis Sci (2003) 1.18
Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect Immun (2004) 1.17
Helicobacter pylori-induced activation of human endothelial cells. Infect Immun (2002) 1.16
Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue. J Clin Pathol (1999) 1.16
Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun (2009) 1.15
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut (2002) 1.14
Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig Dis Sci (1999) 1.12
Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun (1999) 1.11
Novel protein antigen (JHP940) from the genomic plasticity region of Helicobacter pylori induces tumor necrosis factor alpha and interleukin-8 secretion by human macrophages. J Bacteriol (2007) 1.10
Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J Clin Invest (2008) 1.09
Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig Dis Sci (2005) 1.07
cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun (2001) 1.07
Tumor necrosis factor alpha and interleukin 1beta up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection. Infect Immun (2000) 1.07
Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative). Infect Immun (2002) 1.05
Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. Gut (2002) 1.05
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Mol Pathol (2002) 1.04
Retracted Activation of intercellular adhesion molecule 1 expression by Helicobacter pylori is regulated by NF-kappaB in gastric epithelial cancer cells. Infect Immun (2000) 1.04
Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll-like receptor 5-dependent and -independent pathways. Infect Immun (2005) 1.03
The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells. PLoS One (2010) 1.02
Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect Immun (2008) 1.01
Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun (2001) 1.00
Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer. Cancer Microenviron (2009) 1.00
A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol (2010) 1.00
Respiratory syncytial virus and TNF alpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappa B1. BMC Infect Dis (2002) 0.99
Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons. J Clin Microbiol (2005) 0.99
Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene. Infect Immun (2007) 0.99
Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin Diagn Lab Immunol (2005) 0.98
Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol (2010) 0.98
Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun (2003) 0.98
Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun (2001) 0.97
The host protein calprotectin modulates the Helicobacter pylori cag type IV secretion system via zinc sequestration. PLoS Pathog (2014) 0.96
Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol (2010) 0.95
Concurrent proinflammatory and apoptotic activity of a Helicobacter pylori protein (HP986) points to its role in chronic persistence. PLoS One (2011) 0.95
Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell monolayers: role of vacuolating toxin VacA and cag pathogenicity island. Infect Immun (2000) 0.94
Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol (2012) 0.93
cag+ Helicobacter pylori induces homotypic aggregation of macrophage-like cells by up-regulation and recruitment of intracellular adhesion molecule 1 to the cell surface. Infect Immun (2002) 0.93
Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor. J Biol Chem (2008) 0.92
NFκB and AP-1 drive human myometrial IL8 expression. Mediators Inflamm (2012) 0.91
Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine. Front Immunol (2013) 0.91
Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell Microbiol (2013) 0.90
Retracted Helicobacter pylori induces CCL20 expression. Infect Immun (2007) 0.90
Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes (2013) 0.89
Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol (2007) 0.89
Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS One (2011) 0.89
Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells. Dig Dis Sci (2007) 0.89
Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: implications for carcinogenesis. J Gastroenterol (2002) 0.88
Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4. PLoS One (2013) 0.88
CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion. Mol Pathol (2002) 0.88
Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers. J Cell Biochem (2013) 0.87
Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol (2013) 0.87
Secretion of interleukin-8 by human-derived cell lines infected with Mycobacterium bovis. Mediators Inflamm (2004) 0.87
Gastric stem cells and gastric cancer stem cells. Anat Cell Biol (2013) 0.86
Retracted Helicobacter pylori-induced interleukin-12 p40 expression. Infect Immun (2009) 0.85
Pathogenesis of Helicobacter pylori infection. Springer Semin Immunopathol (2005) 0.85
Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron (2008) 0.84
Helicobacter pylori infection in relation to E-cadherin gene promoter polymorphism and hypermethylation in sporadic gastric carcinomas. World J Gastroenterol (2005) 0.83
Interleukin-8 is differentially expressed by human-derived monocytic cell line U937 infected with Mycobacterium tuberculosis H37Rv and Mycobacterium marinum. Infect Immun (2003) 0.83
Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol (2014) 0.83
NF-kappaB and ERK-signaling pathways contribute to the gene expression induced by cag PAI-positive-Helicobacter pylori infection. World J Gastroenterol (2005) 0.81
Differential effects of multiplicity of infection on Helicobacter pylori-induced signaling pathways and interleukin-8 gene transcription. J Clin Immunol (2010) 0.81
Helicobacter pylori: bacterial strategy for incipient stage and persistent colonization in human gastric niches. Yonsei Med J (2014) 0.80
Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immunol (2001) 0.80
Effect of Helicobacter pylori cdrA on interleukin-8 secretions and nuclear factor kappa B activation. World J Gastroenterol (2012) 0.79
BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation. J Immunol (2016) 0.79
Characterization of CagI in the cag pathogenicity island of Helicobacter pylori. Curr Microbiol (2011) 0.79
Dynamic Expansion and Contraction of cagA Copy Number in Helicobacter pylori Impact Development of Gastric Disease. MBio (2017) 0.78
The role of gastrokine 1 in gastric cancer. J Gastric Cancer (2014) 0.78
Induction of CD69 expression by cagPAI-positive Helicobacter pylori infection. World J Gastroenterol (2011) 0.77
Importance of the C-terminal histidine residues of Helicobacter pylori GroES for Toll-like receptor 4 binding and interleukin-8 cytokine production. Sci Rep (2016) 0.76
CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses. World J Gastrointest Oncol (2013) 0.76
Helicobacter pylori CagA Suppresses Apoptosis through Activation of AKT in a Nontransformed Epithelial Cell Model of Glandular Acini Formation. Biomed Res Int (2015) 0.76
Helicobacter pylori and CagA under conditions of iron deficiency. Gut Microbes (2015) 0.75
Nutrition and Helicobacter pylori: Host Diet and Nutritional Immunity Influence Bacterial Virulence and Disease Outcome. Gastroenterol Res Pract (2016) 0.75
A C-Terminal Coiled-Coil Region of CagL is Responsible for Helicobacter Pylori-Induced Il-8 Expression. Eur J Microbiol Immunol (Bp) (2016) 0.75
The inhibitory effect of flavonoids on interleukin-8 release by human gastric adenocarcinoma (AGS) cells infected with cag PAI (+) Helicobacter pylori. Cent Eur J Immunol (2016) 0.75
Interleukin-8 does not influence proliferation of the SGC7901 gastric cancer cell line. Oncol Lett (2014) 0.75
Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells. BMC Microbiol (2016) 0.75
Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer. Oncol Rep (2015) 0.75
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell (1992) 3.25
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature (1998) 2.89
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
c-rel activates but v-rel suppresses transcription from kappa B sites. Proc Natl Acad Sci U S A (1991) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Myonecrosis and myofibrosis as complications of sickle cell anemia. Ann Intern Med (1991) 2.35
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci U S A (1992) 2.29
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis (1993) 2.15
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Cellular fatty acid composition of Campylobacter fetus. J Clin Microbiol (1980) 2.14
Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun (1998) 2.14
Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect (1999) 2.10
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis (1984) 2.04
From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis (1981) 2.04
Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis (1986) 2.04
Allelic Variation within Helicobacter pylori babA and babB. Infect Immun (2001) 2.02
Outbreaks of Campylobacter enteritis in two extended families: evidence for person-to-person transmission. J Pediatr (1981) 2.01
Characteristics of Helicobacter pylori variants selected for urease deficiency. Infect Immun (1992) 2.01
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect Immun (1984) 1.99
Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains. Proc Natl Acad Sci U S A (2000) 1.98
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates. Gastroenterology (1999) 1.96
Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med (1996) 1.96
PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol (1994) 1.96
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus. Infect Immun (1985) 1.88
Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status. Infect Immun (1996) 1.88
Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol (2001) 1.87
Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori. Infect Immun (1992) 1.87